A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

291

Participants

Timeline

Start Date

August 19, 2024

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
HPV-Related Squamous Cell Carcinoma
Interventions
DIAGNOSTIC_TEST

FMISO-PET Scan

Patients will undergo 18F-FMISO scan (only 1 injection) that occurs at week two of radiation treatment, typically day 10 but a window of 8-10 radiation treatment days\* after start of radiation is allowed.

COMBINATION_PRODUCT

Chemoradiation

30 Gy or 70 Gy of radiation in combination with standard chemotherapy (cisplatin, carboplatin, and 5-FU)

COMBINATION_PRODUCT

Chemoradiation

70 Gy of radiation in combination with standard chemotherapy (cisplatin, carboplatin, and 5-FU)

OTHER

Assessments

EQ-5D-5L (5 questions); 2. MDADI-HN (total of 20 questions); 3. COST-FACIT (total of 12 questions).

Trial Locations (9)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

10604

RECRUITING

Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison

11553

RECRUITING

Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale

11725

RECRUITING

Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack

33143

RECRUITING

Baptist Alliance MCI (Data Collection Only), Miami

06102

RECRUITING

Hartford Healthcare (Data Collection Only), Hartford

07920

RECRUITING

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge

07748

RECRUITING

Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown

07645

RECRUITING

Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER